Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Gastrointestinal Biotech Company Renexxion Ireland Announces $100M Investment Commitment 2022-04-12 20:00
New Clinical Advisory Board to support PromarkerD global rollout 2022-04-12 16:04
Abbott Senior Medical Director joins Nutromics as inaugural Chief Medical Officer 2022-04-12 09:28
The NDA of Henlius Novel Anti-PD-1 mAb Serplulimab for the First-Line Treatment of Small Cell Lung Cancer Accepted by NMPA 2022-04-11 22:07
Global pharma organizations back Turn Biotechnologies to advance its cell rejuvenation program 2022-04-11 19:00
APRINOIA Therapeutics received FDA clearance to initiate APNmAb005 Phase 1 clinical trial 2022-04-11 18:00
Frost & Sullivan Hails Sphere Fluidics for Enabling Efficient, Faster, and More Cost-effective Single-cell Analysis with Its Microfluidic Platforms 2022-04-11 18:00
Successful Passing Of The EU Qualified Person Audit Of The Group's Manufacturing Facility For ReCOV In Taizhou 2022-04-11 16:05
Antengene Announces Publication of Five Posters at the 2022 American Association for Cancer Research (AACR) Annual Meeting 2022-04-11 08:30
Telix Pharmaceuticals Announces Licence Agreement with Lilly for Olaratumab 2022-04-11 06:51
Gannex Announces First Patient Dosed in Phase II Clinical Trial of ASC42, an FXR Agonist, for Primary Biliary Cholangitis 2022-04-10 18:20
Biocytogen Signs RenMab™/RenLite™ Licensing Agreement with BeiGene 2022-04-08 21:00
New very-high-sensitivity rapid antigen test kits hit Australian market 2022-04-08 06:00
Henlius' Serplulimab Granted Orphan-Drug Designation in the United States for Small Cell Lung Cancer 2022-04-07 22:21
Rona Therapeutics Announces Completion of $33 Million Series A Financing to Advance Global Discovery and Development of RNA Therapeutics 2022-04-07 12:30
BIO KOREA, Asia's Biggest Bio-Health Convention, to Open in May 2022 2022-04-07 10:14
Antengene's Pivotal "MARCH" Study to Evaluate Selinexor (ATG-010) in Relapsed or Refractory Multiple Myeloma Published in BMC Medicine 2022-04-06 20:03
Ceres Nanosciences Establishes Sixteen Wastewater-Based Epidemiology Centers of Excellence Under NIH RADx Initiative 2022-04-06 19:37
Digital Engagement Continues to Soar Amongst Biopharmas in APAC 2022-04-06 05:00
MGC Pharmaceuticals Enters Partnership with Sciensus Rare for Distribution of Cannabinoids to Treat Refractory Epilepsy, Dementia and Alzheimer's in the EU and UK 2022-04-05 14:00
1 79 80 81 82 83 212